Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis

ConclusionsThis is the largest study of ustekinumab treatment for patients with chronic antibiotic-refractory pouchitis. We found that ustekinumab therapy led to the improvement in clinical and endoscopic endpoints.

Source: Digestive Diseases and Sciences - June 10, 2019 Category: Gastroenterology Source Type: research